Atlas Trials

A Study of the Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Clinical trial NCT06748937 · RECRUITING

Trial details

NCT number
NCT06748937
Sponsor
TASK Applied Science
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2025-03-03
Primary completion
2026-03-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.